AQUILA STUDY IN GERMANY - REAL WORLD ADHERENCE AND PERSISTENCE OF SECUKINUMAB TREATMENT IN ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS PATIENTS - AN INTERIM ANALYSIS

被引：8
|
作者：
Kiltz, Uta [1 ,2 ]
Peterlik, Daniel [3 ]
Winkelmann, Veronika [3 ]
Tony, Hans-Peter [4 ]
机构：
[1] Rheumazentrum Ruhrgebiet, Herne, Germany
[2] Ruhr Univ, Bochum, Germany
[3] Novartis Pharma GmbH, Clin Res Immunol Hepatol & Dermatol, Nurnberg, Germany
[4] Univ Klin, Med Klin 2, Rheumatol Immunol, Wurzburg, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2019年 / 78卷
关键词：
ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; DOUBLE-BLIND;
D O I：
10.1136/annrheumdis-2019-eular.435
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0705
引用
收藏
页码：1814 / 1815
页数：2
相关论文
共 50 条
  • [11] HOW DOES TIME TO DIAGNOSIS AND GENDER AFFECT TREATMENT OUTCOMES IN PATIENTS WITH ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS? - REAL WORLD DATA FROM THE GERMAN AQUILA STUDY WITH SECUKINUMAB
    Benesova, K.
    Hansen, O.
    Kiltz, U.
    Brandt-Juergens, J.
    Kastner, P.
    Riechers, E.
    Peterlik, D.
    Budden, C.
    Boas, A.
    Welle, S.
    Tony, H. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1501 - 1502
  • [12] The role of secukinumab in the treatment of psoriatic arthritis and ankylosing spondylitis
    Garcia-Montoya, Leticia
    Marzo-Ortega, Helena
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (09) : 169 - 180
  • [13] Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
    Alegre-Sancho, Juan Jose
    Nunez-Monje, Victoria
    Campos-Fernandez, Cristina
    Balaguer-Trull, Isabel
    Robustillo-Villarino, Montserrat
    Aguilar-Zamora, Marta
    Garijo-Bufort, Marta
    Pedraz-Penalva, Teresa
    Pena-Gonzalez, Carolina
    de la Morena, Isabel
    Bedoya-Sanchis, Diego
    Yankova-Komsalova, Liliya
    Conesa-Mateos, Arantxa
    Martinez-Cristobal, Anna
    Navarro-Blasco, Francisco Javier
    Senabre-Gallego, Jose Miguel
    Sivera, Francisca
    FRONTIERS IN MEDICINE, 2023, 10
  • [14] Drug Retention and Safety of Secukinumab in a Real-World Cohort of Ankylosing Spondylitis and Psoriatic Arthritis Patients
    Moskal, Mateusz
    Krawiec, Piotr
    Zareba, Wojciech
    Swierczek, Izabella
    Ratusznik, Jakub
    Raputa, Wiktor
    Zielinski, Maciej
    Batko, Krzysztof
    Huk, Mikita
    Batko, Bogdan
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (23)
  • [15] PERSISTENCE AND HEALTHCARE RESOURCE USE (HCRU) IN PATIENTS INITIATING ETANERCEPT TREATMENT FOR ANKYLOSING SPONDYLITIS (AS) OR PSORIATIC ARTHRITIS (PSA) IN GERMANY: A REAL-WORLD ANALYSIS
    Baraliakos, X.
    Poddubnyy, D.
    Behrens, F.
    Curiale, C.
    Tarallo, M.
    Daly, Hernandez A. C.
    Behmer, O.
    Hudson, N.
    Gray, C.
    Cappelleri, J. C.
    VALUE IN HEALTH, 2019, 22 : S432 - S432
  • [16] Uveitis Status in Patients with Ankylosing Spondylitis or Psoriatic Arthritis Under Secukinumab Treatment - Real World Data from a German Observational Study
    Kiltz, Uta
    Brandt-Jrgens, Jan
    Kaestner, Peter
    Riechers, Elke
    Peterlik, Daniel
    Boas, Annika
    Tony, Hans-Peter
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3621 - 3623
  • [17] IMPACT OF INTERMEDIATE TREATMENT INTERRUPTION ON SECUKINUMAB EFFICACY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS: INTERIM ANALYSIS RESULTS FROM THE SERENA STUDY
    Gaffney, Karl
    Kiltz, Uta
    Sfikakis, Petros
    Gullick, Nicola
    Katsifis, Gkikas
    Kandili, Anna
    Brandt-Juergens, Jan
    Goupille, Phillipe
    Maiden, Nicola
    Aassi, Maher
    Schulz, Barbara
    Pournara, Effie
    Jagiello, Piotr
    RHEUMATOLOGY, 2022, 61
  • [18] Impact of Intermediate Treatment Interruption on Secukinumab Efficacy in Patients with Active Psoriatic Arthritis and Ankylosing Spondylitis: Interim Analysis Results from the SERENA Study
    Kiltz, Uta
    Sfikakis, Petros
    Gullick, Nicola
    Katsifis, Gkikas
    Kandyli, Anna
    Brandt-Jrgens, Jan
    Goupille, Philippe
    Maiden, Nicola
    Gaffney, Karl
    Aassi, Maher
    Schulz, Barbara
    Pournara, Effie
    Jagiello, Piotr
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2843 - 2845
  • [19] Impact of Weight and Sex on Long-term Persistence to Secukinumab Treatment in Patients with Active Psoriatic Arthritis or Ankylosing Spondylitis
    Kiltz, Uta
    Sfikakis, Petros P.
    Gullick, Nicola
    Theodoridou, Athina
    Kandyli, Anna
    Brandt-Juergens, Jan
    Goupille, Philippe
    Maiden, Nicola
    Gaffney, Karl
    Peterlik, Daniel
    Schulz, Barbara
    Pournara, Effie
    Jagiello, Piotr
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2067 - 2069
  • [20] Real World Secukinumab Study in Ankylosing Spondylitis and Psoriatic Arthritis - Comorbidities and Extraarticular Manifestations: Incidence and Status throughout a Non-Interventional Study in Germany
    Kiltz, Uta
    Kaestner, Peter
    Krauel, Holger
    Schwarze, Ilka
    Brandt-Juergens, Jan
    Maier-Peuschel, Monika
    Legeler, Carolin
    Veit, Justyna
    Tony, Hans-Peter
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345